You have 9 free searches left this month | for more free features.

68Ga-pentixafor

Showing 1 - 25 of 1,836

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thymoma Trial in Beijing (68Ga-Pentixafor)

Recruiting
  • Thymoma
  • 68Ga-Pentixafor
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Oct 11, 2023

Multiple Myeloma Trial in Beijing (68Ga-Pentixather, 68Ga-Pentixafor)

Recruiting
  • Multiple Myeloma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 3, 2022

CNS Lymphoma Trial (68Ga-PTF)

Recruiting
  • CNS Lymphoma
  • Aalborg, Denmark
  • +1 more
Jan 17, 2023

Positron-Emission Tomography Trial in Fuzhou (68Ga-Pentixafor)

Recruiting
  • Positron-Emission Tomography
  • 68Ga-Pentixafor
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Jul 27, 2022

68Ga-Pentixafor PET/CT for Subtyping Diagnosis of Primary

Completed
  • Primary Aldosteronism
  • 68Ga-Pentixafor PET/CT imaging
  • Chongqing, Chongqing, China
    The First Affilated Hospital of Chongqing Medical University
Jul 13, 2022

Non-Hodgkin Lymphoma, Multiple Myeloma Trial in New York ([68Ga]-Pentixafor)

Recruiting
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 4, 2022

Neuroendocrine Tumors Trial in Iowa City ([68Ga]Pentixafor)

Recruiting
  • Neuroendocrine Tumors
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center
Mar 16, 2022

Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

Not yet recruiting
  • Marginal Zone Lymphoma
  • (no location specified)
Nov 6, 2023

Acute Cellular Graft Rejection, Cardiac Sarcoidosis, Myocarditis Due to Drug Trial in Lausanne ([68Ga]Ga-PentixaFor PET/CT)

Not yet recruiting
  • Acute Cellular Graft Rejection
  • +2 more
  • [68Ga]Ga-PentixaFor PET/CT
  • Lausanne, Vaud, Switzerland
    Centre Hospitalier Universitaire Vaudois
Aug 11, 2022

Multiple Myeloma Trial in Nantes ([68Ga]Ga-PentixaFor)

Not yet recruiting
  • Multiple Myeloma
  • Nantes, France
    CHU de Nantes
Apr 4, 2022

CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)

Not yet recruiting
  • CXCR4
  • +2 more
  • 68Ga-pentixafor
  • PET/CT
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Feb 15, 2022

Multiple Myeloma Trial in Nantes ([68Ga]Ga-PentixaFor)

Recruiting
  • Multiple Myeloma
  • Nantes, France
    Nantes UH
Sep 24, 2021

Lymphoma, Multiple Myeloma, Leukemia Trial in Fuzhou (68Ga-Pentixafor)

Recruiting
  • Lymphoma
  • +2 more
  • 68Ga-Pentixafor
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Apr 6, 2021

Aldosterone-Producing Adenoma Trial (CXCR4)

Not yet recruiting
  • Aldosterone-Producing Adenoma
  • CXCR4
  • (no location specified)
Apr 20, 2023

Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • PET/CT
  • Hefei, Anhui, China
    The First Affiliated Hospital of China University of Science and
Jul 19, 2023

Adrenal Mass Trial in Peking (Gallium-68 Pentixafor PET/CT)

Unknown status
  • Adrenal Mass
  • Gallium-68 Pentixafor PET/CT
  • Peking, China
    Peking Union Medical College Hospital
Apr 22, 2021

Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)

Recruiting
  • Prostate Cancer
  • Nanjing, Jiangsu, China
    68Ga-PSMA-33 PET/CT imaging
Sep 19, 2023

Tumor Positron-Emission Tomography Trial in Fuzhou (68Ga-DOTATATE and 68Ga-FAPI)

Recruiting
  • Tumor Positron-Emission Tomography
  • 68Ga-DOTATATE and 68Ga-FAPI
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 7, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Spondyloarthritis, Axial Spondyloarthritis, Ankylosing Spondylitis Trial in Xiamen (Drug: 68Ga-FAPI)

Recruiting
  • Spondyloarthritis
  • +2 more
  • Drug: 68Ga-FAPI
  • Xiamen, Fujian, China
    The first affiliated hospital of Xiamen University
Aug 13, 2023

Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)

Recruiting
  • Bladder Cancer
  • [68Ga]-NOTA-SGC8
  • Shanghai, Shanghai, China
    Renji Hospital
Aug 14, 2023

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy

Recruiting
  • Primary Myelofibrosis
  • 68Ga FAPI PET/CT
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography

Recruiting
  • Hepatocellular Carcinoma
  • Gallium Ga 68 Gozetotide
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

Myositis, Idiopathic Inflammatory Myopathies Trial in Xiamen (68Ga-FAPI)

Recruiting
  • Myositis
  • Idiopathic Inflammatory Myopathies
  • Xiamen, Fujian, China
    The first affiliated hospital of Xiamen University
Jul 12, 2023

Hepatocellular Carcinoma Trial in Shanghai ([68Ga]Ga-NOTA-RG2 PET Imaging)

Recruiting
  • Hepatocellular Carcinoma
  • [68Ga]Ga-NOTA-RG2 PET Imaging
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023